ArticlePharmacoepidemiology and drug safety2016

The experience of accommodating privacy restrictions during implementation of a large-scale surveillance study of an osteoporosis medication.

Kirk D Midkiff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.